Meteora Capital’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.71M Sell
256,254
-14,589
-5% -$154K 0.2% 113
2025
Q4
$2.83M Buy
+270,843
New +$2.82M 0.24% 94

Other funds holding TDAC

Meteora Capital's TDAC Position: Q1 2026 in Review

Meteora Capital reduced its Translational Development Acquisition Corp (TDAC) stake by 5.4% in Q1 2026, selling an estimated $154K and leaving 256,254 shares worth $2.71M. The position accounts for 0.2% of the portfolio, ranked #113.

Meteora Capital first reported a position in TDAC in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.83M in Q4 2025. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Meteora Capital held 256,254 shares of Translational Development Acquisition Corp worth $2.71M as of Q1 2026.
  • Meteora Capital sold 14,589 Translational Development Acquisition Corp shares in Q1 2026, an estimated $154K.
  • Translational Development Acquisition Corp made up 0.2% of Meteora Capital's portfolio in Q1 2026, its #113 holding.
  • Meteora Capital first reported a position in Translational Development Acquisition Corp in Q4 2025 and has held it in 2 quarters since.
  • Meteora Capital's Translational Development Acquisition Corp position peaked at $2.83M in Q4 2025.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Meteora Capital's 13F filing for Q1 2026, filed 15 May 2026.